Why Investors Shouldn't Be Surprised By Sino Biopharmaceutical Limited's (HKG:1177) 31% Share Price Surge
Aug 04
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Pharma Industry Analysis
UpdatedAug 10, 2025
DataAggregated Company Financials
Companies38
- 7D0.9%
- 3M48.4%
- 1Y72.7%
- YTD80.5%
Last week, the Pharma industry hasn't moved much but CSPC Pharmaceutical Group is up 3.7% in that time. As for the the longer term, the industry is up 73% over the past 12 months. As for the next few years, earnings are expected to grow by 12% per annum.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 10 Aug 2025 | HK$768.1b | HK$475.0b | HK$29.0b | 11.5x | 26.4x | 1.6x |
| Tue, 08 Jul 2025 | HK$651.9b | HK$475.7b | HK$28.8b | 11.6x | 22.7x | 1.4x |
| Thu, 05 Jun 2025 | HK$612.7b | HK$476.0b | HK$28.7b | 11x | 21.3x | 1.3x |
| Sat, 03 May 2025 | HK$513.2b | HK$467.5b | HK$28.6b | 10.4x | 17.9x | 1.1x |
| Mon, 31 Mar 2025 | HK$491.2b | HK$469.9b | HK$29.1b | 9.4x | 16.9x | 1x |
| Wed, 26 Feb 2025 | HK$448.4b | HK$462.7b | HK$31.9b | 8.5x | 14.1x | 1x |
| Fri, 24 Jan 2025 | HK$404.9b | HK$462.1b | HK$31.9b | 8.4x | 12.7x | 0.9x |
| Sun, 22 Dec 2024 | HK$431.9b | HK$460.7b | HK$31.8b | 8.4x | 13.6x | 0.9x |
| Tue, 19 Nov 2024 | HK$432.9b | HK$463.7b | HK$31.5b | 8.3x | 13.8x | 0.9x |
| Thu, 17 Oct 2024 | HK$481.7b | HK$471.5b | HK$32.8b | 7.8x | 14.7x | 1x |
| Sat, 14 Sep 2024 | HK$430.7b | HK$474.2b | HK$32.9b | 7.3x | 13.1x | 0.9x |
| Mon, 12 Aug 2024 | HK$440.9b | HK$463.5b | HK$32.9b | 7.4x | 13.4x | 1x |
| Wed, 10 Jul 2024 | HK$424.3b | HK$457.8b | HK$32.5b | 7.4x | 13.1x | 0.9x |
| Fri, 07 Jun 2024 | HK$473.2b | HK$463.7b | HK$33.9b | 8.4x | 14x | 1x |
| Sun, 05 May 2024 | HK$475.2b | HK$463.3b | HK$33.7b | 7.6x | 14.1x | 1x |
| Tue, 02 Apr 2024 | HK$445.8b | HK$465.2b | HK$36.5b | 7.7x | 12.2x | 1x |
| Thu, 29 Feb 2024 | HK$441.5b | HK$470.7b | HK$33.5b | 7.7x | 13.2x | 0.9x |
| Sat, 27 Jan 2024 | HK$418.1b | HK$472.7b | HK$33.8b | 7x | 12.4x | 0.9x |
| Mon, 25 Dec 2023 | HK$464.0b | HK$472.7b | HK$33.8b | 7.5x | 13.7x | 1x |
| Wed, 22 Nov 2023 | HK$508.5b | HK$472.5b | HK$32.3b | 7.1x | 15.7x | 1.1x |
| Fri, 20 Oct 2023 | HK$424.3b | HK$469.1b | HK$31.5b | 6.7x | 13.5x | 0.9x |
| Sun, 17 Sep 2023 | HK$429.5b | HK$470.1b | HK$31.6b | 6.7x | 13.6x | 0.9x |
| Tue, 15 Aug 2023 | HK$441.0b | HK$446.1b | HK$28.2b | 8.8x | 15.7x | 1x |
| Thu, 13 Jul 2023 | HK$475.2b | HK$446.6b | HK$27.9b | 9.3x | 17x | 1.1x |
| Sat, 10 Jun 2023 | HK$512.9b | HK$448.1b | HK$27.8b | 8.9x | 18.4x | 1.1x |
| Mon, 08 May 2023 | HK$571.5b | HK$453.4b | HK$28.5b | 9.2x | 20.1x | 1.3x |
| Wed, 05 Apr 2023 | HK$531.9b | HK$452.8b | HK$28.9b | 9.2x | 18.4x | 1.2x |
| Fri, 03 Mar 2023 | HK$605.5b | HK$443.6b | HK$34.0b | 11.6x | 17.8x | 1.4x |
| Sun, 29 Jan 2023 | HK$645.5b | HK$447.3b | HK$35.6b | 10.8x | 18.1x | 1.4x |
| Tue, 27 Dec 2022 | HK$585.3b | HK$442.0b | HK$34.7b | 10.6x | 16.8x | 1.3x |
| Thu, 24 Nov 2022 | HK$576.4b | HK$437.1b | HK$33.9b | 9.2x | 17x | 1.3x |
| Sat, 22 Oct 2022 | HK$570.7b | HK$512.7b | HK$38.8b | 8.9x | 14.7x | 1.1x |
| Mon, 19 Sep 2022 | HK$528.7b | HK$518.6b | HK$40.6b | 9.2x | 13x | 1x |
| Wed, 17 Aug 2022 | HK$580.2b | HK$512.3b | HK$51.2b | 7.8x | 11.3x | 1.1x |
Price to Earnings Ratio
11.3x
Current Industry PE
- Investors are optimistic on the Hong Kong Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 26.4x which is higher than its 3-year average PE of 15.6x.
- The 3-year average PS ratio of 1.1x is lower than the industry's current PS ratio of 1.6x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 17% per year over the last three years,
- Revenues have also declined 2.5% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 2.90% | |
| Healthcare | 2.27% | |
| Pharma | 0.92% | |
| Pharma | 0.92% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 1093 CSPC Pharmaceutical Group | HK$10.26 | 3.7% +HK$4.2b | 74.8% | PE25.6x | |
| 3692 Hansoh Pharmaceutical Group | HK$35.38 | 1.4% +HK$2.9b | 87.0% | PE44x | |
| 3933 United Laboratories International Holdings | HK$15.13 | 3.9% +HK$1.1b | 76.8% | PE10.3x | |
| 1477 Ocumension Therapeutics | HK$10.57 | 12.2% +HK$935.9m | 44.8% | PS18.9x | |
| 460 Sihuan Pharmaceutical Holdings Group | HK$1.38 | 6.2% +HK$730.2m | 160.4% | PS6.1x |
